{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:30:06Z","timestamp":1760027406838},"reference-count":14,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&T"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5582\/ddt.2016.01064","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:09:18Z","timestamp":1485382158000},"page":"47-50","source":"Crossref","is-referenced-by-count":3,"title":["Rivaroxaban-induced chest wall spontaneous expanding hematoma"],"prefix":"10.5582","volume":"11","author":[{"given":"Nikolaos S.","family":"Salemis","sequence":"first","affiliation":[{"name":"Second Department of Surgery\/Breast Surgery Unit, Army General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Koscielny J, Rutkauskaite E. Rivaroxaban and hemostasis in emergency care. Emerg Med Int. 2014; 2014:935474.","DOI":"10.1155\/2014\/935474"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kreutz R. Pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor. Curr Clin Pharmacol. 2014; 9:75-83.","DOI":"10.2174\/1574884708666131111204658"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS; EINSTEIN Investigators. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: A pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013; 11:21.","DOI":"10.1186\/1477-9560-11-21"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Coleman R, MacCallum P. Treatment and secondary prevention of venous thromboembolism in cancer. Br J Cancer. 2010; 102 (Suppl 1):S17-23.","DOI":"10.1038\/sj.bjc.6605601"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002; 100:3484-3488.","DOI":"10.1182\/blood-2002-01-0108"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. EINSTEIN Investigators, Bauersachs R, Berkowitz SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010; 363:2499-2510.","DOI":"10.1056\/NEJMoa1007903"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Beyer-Westendorf J, F\u00f6rster K, Pannach S, Ebertz F, Gelbricht V, Thieme C, Michalski F, K\u00f6hler C, Werth S, Sahin K, Tittl L, H\u00e4nsel U, Weiss N. Rates, management, and outcome of rivaroxaban bleeding in daily care: Results from the Dresden NOAC registry. Blood. 2014; 124:955-962.","DOI":"10.1182\/blood-2014-03-563577"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tamayo S, Frank Peacock W, Patel M, Sicignano N, Hopf KP, Fields LE, Sarich T, Wu S, Yannicelli D, Yuan Z. Characterizing major bleeding in patients with nonvalvular atrial fibrillation: A pharmacovigilance study of 27467 patients taking rivaroxaban. Clin Cardiol. 2015; 38:63-68.","DOI":"10.1002\/clc.22373"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wells PS, Theberge IA, Bowdridge JC, Forgie MA, Carrier M. PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease. Thromb Res. 2016; 140 (Suppl 1):S191-192.","DOI":"10.1016\/S0049-3848(16)30174-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bott-Kitslaar DM, Saadiq RA, McBane RD, Loprinzi CL, Ashrani AA, Ransone TR, Wolfgram AA, Berentsen MM, Wysokinski WE. Efficacy and safety of rivaroxaban in patients with venous thromboembolism and active malignancy: A single-center registry. Am J Med. 2016; 129:615-619.","DOI":"10.1016\/j.amjmed.2015.12.025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015; 373:2413-2424.","DOI":"10.1056\/NEJMoa1510991"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Trujillo-Santos J, Nieto JA, Ru\u00edz-Gamietea A, L\u00f3pez-Jim\u00e9nez L, Garc\u00eda-Bragado F, Quintavalla R, Monreal M; RIETE Investigators. Bleeding complications associated with anticoagulant therapy in patients with cancer. Thromb Res. 2010; (125 Suppl 2):S58-61.","DOI":"10.1016\/S0049-3848(10)70015-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kamphuisen PW, Beyer-Westendorf J. Bleeding complications during anticoagulant treatment in patients with cancer. Thromb Res. 2014; 133 (Suppl 2):S49-55.","DOI":"10.1016\/S0049-3848(14)50009-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245.","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Drug Discoveries & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/11\/1\/11_2016.01064\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:03:45Z","timestamp":1498381425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/11\/1\/11_2016.01064\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2016.01064","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}